600
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Study of risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: Correlation to serum testosterone levelFootnoteFootnote

&
Pages 319-321 | Received 07 Nov 2017, Accepted 17 Jan 2018, Published online: 17 May 2019

Abstract

Background

Diabetes mellitus (DM) is one of the most frequent etiologies of erectile dysfunction (ED). Risk factors of ED in type 2 diabetes mellitus (T2 DM) include patient age, disease duration, sedentary life and glycemic control. Subnormal testosterone concentrations contribute to ED as testosterone regulates nearly every component of erectile function.

The aim of the work was to study the age of the patient, duration of diabetes mellitus, body mass index (BMI), glycosylated hemoglobin (HbAIc) and urinary albumin creatinine ratio (uACR) in type 2 male diabetic patients as risk factors for erectile dysfunction and their relation to serum testosterone level.

Patients and methods

This study was conducted on 100 male type 2 diabetics selected from inpatient department and out patient clinics of the Internal Medicine Department in Menoufia University Hospital. The patients were divided into two groups: Group 1: 50 patients with type 2 DM with erectile dysfunction and Group 2: 50 patientswith type 2 DM without erectile dysfunction. The study groups were subjected to thorough history with special emphasis on age of the patients, disease duration and investigations including testosterone level, glycosylated hemoglobin, and uACR. The patients answered the abridged 5-item version of the International Index of Eectile Function (IIEF-5) questionnaire.

Results

Total serum testosterone was significantly lower in diabetics with ED compared to those without ED. HbAIc, diabetes duration and uACR were independently negatively correlated with testosterone level.

Conclusion

The diabetes duration, glycemic control and uACR contribute to erectile dysfunction in type 2 diabetics, and they were independently and negatively correlated with total serum testosterone level.

1 Introduction

The long term complications of diabetes include dysfunction of different organs and sexual dysfunction.Citation1

ED is defined as the persistent inability to achieve or maintain penile erection sufficient for satisfactory sexual performance.Citation2 Persistence of ED over 3 months has been suggested as a reasonable clinical guideline.Citation3

There are a lot of risk factors for ED in diabetic patients.Citation4 Subnormal testosterone levels were found in diabetic men and contribute to ED.Citation5

This study was designed to study the patient's age, diabetes duration, HbA1c, uACR and BMI as risk factors for ED in type 2 male diabetics and their correlation to serum testosterone level.

2 Patients and methods

This study was conducted on 100 male type 2 diabetic patients aged above 40 years and with duration of diabetes more than 5 years. The patients selected from inpatient and outpatient clinics of the Internal Medicine department in Menoufia University. The protocol of the study was approved by the ethical committee of Faculty of Medicine. The selected patients gave consent for participation in the study before they were exposed to examination and investigations. The study was done from June 2017 to August 2017.

The diabetic patients were divided into two groups:

  • Group 1: 50 male patients with type 2 diabetes with erectile dysfunction.

  • Group 2: 50 male patients with type 2 diabetes without erectile dysfunction.

Exclusion criteria included advanced liver or renal diseases, malignancy, use of medications that cause hypogonadism or those receiving testosterone or steroid, history of head trauma, pelvic trauma and surgery.

Patients of the study were subjected to thorough history taking with special emphasis on the age, duration of diabetes mellitus and detailed drug history. Complete physical examination was done including weight and height to calculate body mass index.

Investigations included liver profile, complete blood picture, glycosylated hemoglobin, blood urea and creatinine, complete urine analysis, urine albumin creatinine ratio and total serum testosterone level were done.

The patients were asked to answer the abridged 5 – item version of the International Index of Erectile Function (IIEF-5) questionnaire.Citation6 This questionnaire consists of 5 questions each of them is scored on five – point ordinal score where the lower values represent poor erectile function. Patients with score less than 22 were considered to have erectile dysfunction.Citation7 All patients filled the Arabic version of IIEF-5 questionnaire by themselves.

3 Statistical methodology

Data were analyzed using Statistical Package for Social Science (SPSS) software computer program version 15, (IBM Corp, IBM SPSS Statistics for Windows, Version 15.0 Armonk, NY:IBM Corp. Chicago, USA) Quantitative data were described using mean and standard deviation. Significance level (P) value was P less than or equal to 0.05.

4 Results

The mean age, Glycosylated hemoglobin, BMI and uACR were statistically significantly higher in group 1 compared with group 2. Total Serum testosterone level was statistically significantly lower in group 1 compared with group 2 (). Total serum testosterone level was significantly negatively correlated with the duration of diabetes, HbAIc, BMI and uACR ().

Table 1 Comparison between the studied groups according to demographic and laboratory data.

Table 2 Correlation between total serum testosterone and studied parameters.

Only duration of diabetes, HbAIc and uACR were independently negatively correlated with total serum testosterone level ().

Table 3 Linear regression for the studied parameters affecting total serum testosterone.

5 Discussion

Diabetes mellitus is a major health problem worldwide. The association between hypogonadism and diabetes mellitus has recently received substantial attention.Citation8

The present study reported that the age of the patients with ED was significantly higher than the age of those without ED. The is similar to cross sectional study by Giuliano et al.Citation9 on population of 7689 patients in Italy [including 3563 patients with DM] confirmed the relation between increasing age and increasing prevalence of ED. The same results obtained from other studies.Citation10,Citation11

On the other hand, studies conducted by Ghazi et al.Citation8 and Romeo et al.Citation12 did not consider age as a risk factor for ED.

The result of the current study showed that diabetic patients with ED had significantly longer duration of diabetes when compared to those without ED and that total testosterone level was independently negatively correlated with the duration of diabetes. This is in agreement with an observational study on total of 5477 Chinese men with type 2 DM by Yang et al.Citation13 found that the duration of DM was significantly associated with the presence and severity of ED.

Comparably, a study on 3980 diabetic men aged 30–69 years was performed by Selim et al.Citation14 reported that the frequency of ED increased with duration of DM, ranging from 44.6% for DM lasting <5 years to 88.9% for DM > 20 years and that patients with ED had a longer duration of DM than those without ED.

Similar to our study, Al Hayek et al.Citation15 and Corona et al.Citation16 reported that the prevalence of low testosterone was higher in patients with a longer duration of DM. Also, another study on 123 men with T2 DM by shaheen et al.Citation17 showed a negative correlation between serum testosterone and duration of diabetes. On the other hand Dhindsa et al.Citation1 and Mirzae et al.Citation19 reported no significant correlation between hypogonadism and duration of diabetes.

In the present study group 1 patients had significantly higher BMI than group 2 patients. Also there was a significant negative correlation between BMI and testosterone level. A large study on ED, the Health Professionals Follow up Study [HPF5] which included 22,086 United States men from 40 to 75 years old has found BMI was inversely associated with the risk of ED development.Citation20 Another study by Hofstra et al.Citation21 on 160 obese men, the final analysis showed that more forty percent of those with morbid obesity had low serum testosterone.

The results of our study showed that patients with ED had significantly higher HbAIc when compared to patients without ED and HbAIc was found to be independently negatively correlated with testosterone level. These results in agreement with a study by Rabijewski et al.Citation22 reported significant negative correlation between HbA1c and testosterone concentration in type 2 DM. Moreover Aboelanga and ElShaway.Citation23 reported that HbAIc was a significant predictor for total testosterone in type 2 diabetic patients and risk factor for male hypogonadism.

Chronic hyperglycemia induces derangement on vascular and neuronal cells including hemodynamic alteration, endothelial dysfunction, accumulation of advanced glycated end products and activation of inflammatory cells either by generating toxic and reactive metabolites or altering intracellular signaling pathways which can suppress release of pituitary gonadotrophins in states of hyperglycemia.Citation24

In our study uACR was significantly higher in group 1 compared to group 2 and it was independently statistically significantly negatively correlated with total serum testosterone. In agreement with the results reported by Chuang et al.Citation25 who conducted a study on 455 patients to evaluate the association of albuminuria as a risk factor for ED in men with T2 DM. They found that albuminuria was an important risk factor for ED in men with diabetes after adjustment of age and diabetes mellitus duration. Similarly Yu et al.Citation26 in a study conducted on 313 patients with T2 DM have also reported higher prevalence of albuminuria and that higher uACR associated with ED severity.

The explanation of this relation between hypogonadism and albuminuria is not well established. However, albuminuria is considered as a marker of vascular endothelial damage and chronic low grade inflammation.Citation27 It is postulated that albuminuria might be a marker for microvascular affection of hypothalamus in diabetic patients which will lead to disturbed release of gonadotropic releasing hormones causing hypogonadism.Citation23

The present study showed that patients with ED had significantly lower total serum testosterone levels than those without ED. In agreement with the results reported by Ghazi et al.Citation8 who found that 94% of type 2 diabetic patients with low serum testosterone had ED versus 61% for the patients with normal serum testosterone. Similarly, El Saghier et al.Citation28 reported that patients with ED had lower testosterone than those without ED and that 85.7% of T2 DM patients with low serum testosterone had ED versus 31% of those with normal testosterone.

This hypogonadal state may be due to hypogonadotrophic hypogonadism which is mostly secondary to chronic disease such as T2 DM which could be associated with impaired function of hypothalamic Pituitary testicular axis.Citation18

6 Conclusion

Type 2 diabetic patients with erectile dysfunction have high prevalence of low serum testosterone level which significantly negatively correlated with duration of diabetes, HbAIc and uACR. So such risk factors should be considered and may play an important role in erectile dysfunction in type 2 diabetic patients.

Financial support and Sponsorship

Nill.

Conflict of interest

There are no conflicts of interest.

Source of support

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Notes

Peer review under responsibility of Alexandria University Faculty of Medicine.

Available online 13 February 2018

References

  • A.J.BoultonA.I.VinikJ.C.ArezzoDiabetic neuropathies: a statement by the American Diabetes AssociationDiabetes Care282005956962
  • NIH Consensus ConferenceImpotence. NIH Consensus Development Panel on ImpotenceJAMA270119938390
  • H.A.FeldmanI.GoldsteinD.G.HatzichristouR.J.KraneJ.B.McKinlayImpotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging StudyJ Urol151119945461
  • J.M.JabaloyasHormonal etiology in erectile dysfunctionArch Esp Urol6382010621627
  • A.M.TraishA.T.GuayAre androgens critical for penile erections in humans? Examining the clinical and preclinical evidenceJ Sex Med.32006382404
  • R.C.RosenJ.C.CappelleriM.D.SmithJ.LipskyB.M.PeñaDevelopment and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunctionInt J Impot Res111999319326
  • R.ShamloulH.GhanemA.Abou-zeidValidity of the Arabic version of the sexual health inventory for men among EgyptiansInt J Impot Res1652004452455
  • S.GhaziW.ZohdyY.ElkhiatR.ShamloulSerum testosterone levels in diabetic men with and without erectile dysfunctionAndrologia442012373380
  • F.A.GiulianoA.LericheE.O.JaudinotA.S.de GendrePrevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or bothUrology64200411961201
  • A.Martin-MoralesJ.J.Sanchez-CruzI.Saenz de TejadaPrevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina StudyJ Urol16622001569574
  • F.KhatibN.JarrahN.ShegemSexual dysfunction among Jordanian men with diabetesSaudi Med J2732006351356
  • J.H.RomeoA.D.SeftelZ.T.MadhunD.C.AronSexual function in men with diabetes type 2: association with glycemic controlJ Urol1632000788791
  • G.YangC.PanJ.LuPrevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitusInt J Impot Res2252010310317
  • S.SelimS.H.ChowdhuryA.K.AzadM.A.J.ChowdhuryF.R.RahamanFrequency and Risk factors of Erectile Dysfunction in Bangladeshi Diabetic menJ Endocrinol Diabetes Obes3320151075
  • A.A.Al HayekY.S.KhaderS.JafalPrevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional studyJ Family Community Med2032013179186
  • G.CoronaE.MannucciL.PetroneAssociation of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinicInt J Impot Res182006190197
  • D.A.ShaheenD.A.ShahinA.A.HabibA.M.El AminThe effect of serum free testosterone level on glycemic control and atherosclerosis in type 2 diabetic menAdv Biochem2220143439
  • S.DhindsaS.PrabhakarM.SethiFrequent occurrence of hypogonadotropic hypogonadism in type 2 diabetesJ Clin Endocrinol Metab89200454625468
  • M.R.MirzaeiM.AminiA.AminorroayaThe prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, IsfahanIran. J Res Medi Sci1772012602606
  • C.G.BaconM.A.MittlemanI.KawachiA prospective study of risk factors for erectile dysfunctionJ Urol17612006217221
  • J.HofstraS.LovesB.van WageningenHigh prevalence of hypogonadotropic hypogonadism in men referred for obesity treatmentNeth J Med662008103109
  • M.RabijewskiL.PapierskaW.ZgliczyńskiP.PiątkiewiczThe incidence of hypogonadotropic hypogonadism in type 2 diabetic men in polish populationBiomed Res Int20132013767496
  • M.M.AboelnagaH.ElshahawyPrevalence and predictors for low total testosterone levels among male type 2 diabetic patients: an Egyptian experienceInt J Res Med Sci48201733813387
  • T.J.GuzikD.MangalatR.KorbutAdipocytokines: novel link between inflammation and vascular function?J Physiol Pharmacol572006505528
  • Y.C.ChuangM.S.ChungP.W.WangAlbuminuria is an independent risk factor of erectile dysfunction in men with type 2 diabetesJ Sex Med9201110551064
  • L.W.YuA.P.KongP.C.TongPredictors for erectile dysfunction among diabeticsDiabetes Res Clin Practice712006313319
  • M.J.HasanA.MuqueetA.SharmeenM.R.HoquePrevalence of microalbuminuria in relation to glycemic control in type-2 diabetic patients in MymensinghMymensingh Med J24120151824
  • E.O.El SaghierS.E.SheblO.A.FawzyAndrogen Deficiency and Erectile Dysfunction in Patients with Type 2 DiabetesClin Med Insights Endocrinol Diabetes820155562